Pachipulusu Rajesh <br/><br/>
US FDA regulatory requirements for ANDA submission and review phase assessment 

 - 1 
 -  2019 
 - 191p. 
<br/><br/>Pramod Kumar T.M 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Pharmaceutics - Regulations
<br/><br/><label>Dewey Class. No.: </label>615.4 PAC